Rohto PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Rohto PharmaceuticalLtd has a total shareholder equity of ¥246.0B and total debt of ¥9.6B, which brings its debt-to-equity ratio to 3.9%. Its total assets and total liabilities are ¥342.2B and ¥96.2B respectively. Rohto PharmaceuticalLtd's EBIT is ¥40.5B making its interest coverage ratio -16. It has cash and short-term investments of ¥81.9B.
Key information
3.9%
Debt to equity ratio
JP¥9.63b
Debt
| Interest coverage ratio | -16x |
| Cash | JP¥81.88b |
| Equity | JP¥246.01b |
| Total liabilities | JP¥96.15b |
| Total assets | JP¥342.16b |
Recent financial health updates
Recent updates
These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely
Apr 03
Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching
Mar 21Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year
Mar 07Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)
Feb 26Financial Position Analysis
Short Term Liabilities: 4527's short term assets (¥214.2B) exceed its short term liabilities (¥83.6B).
Long Term Liabilities: 4527's short term assets (¥214.2B) exceed its long term liabilities (¥12.5B).
Debt to Equity History and Analysis
Debt Level: 4527 has more cash than its total debt.
Reducing Debt: 4527's debt to equity ratio has reduced from 4.4% to 3.9% over the past 5 years.
Debt Coverage: 4527's debt is well covered by operating cash flow (297%).
Interest Coverage: 4527 earns more interest than it pays, so coverage of interest payments is not a concern.